GlassScriptPhysician profile
Brian B Draper
NPI 1316225295
$8,330.27
in general payments reported to CMS, 2019-2025
17 companies · $3,399 in 2025
The $3,399 reported for 2025 was more than what 87% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $33.42 · 2021: $211 · 2022: $1,349 · 2023: $1,583 · 2024: $1,755 · 2025: $3,399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,790 · Food and Beverage: $2,616 · Travel and Lodging: $1,322 · Education: $9.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,790.00 |
| Food and Beverage | $2,615.70 |
| Travel and Lodging | $1,322.08 |
| Education | $9.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $4,133.18 | 2023-2025 | Matrixrib |
| Depuy Synthes Sales INC. | $1,417.50 | 2021-2025 | Matrixrib, Xcm Biologic Tissue Matrix, Matrixmidface |
| Avita Medical Americas, LLC | $644.87 | 2021-2024 | Recell |
| Smith+Nephew, INC. | $442.28 | 2021-2025 | Collagenase Santyl |
| Polynovo North America LLC | $425.06 | 2021-2025 | Novosorb Btm |
| Acera Surgical, INC. | $361.89 | 2022-2025 | Restrata Wound Matrix |
| Davol INC. | $223.15 | 2021-2025 | Phasix Mesh |
| Polymedics Innovations INC. | $218.65 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $143.96 | 2024 | Andexxa |
| Ethicon US, LLC | $71.99 | 2022 | |
| Haemonetics Corporation | $63.10 | 2023-2025 | Teg6s Hemostasis System |
| Vericel Corporation | $62.42 | 2022-2025 | Nexobrid |
| Portola Pharmaceuticals, LLC | $33.42 | 2020 | |
| Kls-Martin L.P. | $25.60 | 2021-2022 | |
| Access Pro Medical, LLC | $23.47 | 2025 | Matriderm |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $20.11 | 2022 | |
| Solventum Corporation | $19.62 | 2025 | V.A.C. Veraflo Cleanse Choice |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Draper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.